These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36267414)

  • 1. Identification and verification of IGFBP3 and YTHDC1 as biomarkers associated with immune infiltration and mitophagy in hypertrophic cardiomyopathy.
    Li Y; Zhang W; Dai Y; Chen K
    Front Genet; 2022; 13():986995. PubMed ID: 36267414
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioinformatics and Immune Infiltration Analyses Reveal the Key Pathway and Immune Cells in the Pathogenesis of Hypertrophic Cardiomyopathy.
    Zhang XZ; Zhang S; Tang TT; Cheng X
    Front Cardiovasc Med; 2021; 8():696321. PubMed ID: 34497835
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of the Immune Status of Hypertrophic Cardiomyopathy by Integrated Analysis of Bulk- and Single-Cell RNA Sequencing Data.
    Zhao W; Wu T; Zhan J; Dong Z
    Comput Math Methods Med; 2022; 2022():7153491. PubMed ID: 36238494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive analysis of m6A/m7G/m5C/m1A-related gene expression and immune infiltration in liver ischemia-reperfusion injury by integrating bioinformatics and machine learning algorithms.
    Meng Z; Li X; Lu S; Hua Y; Yin B; Qian B; Li Z; Zhou Y; Sergeeva I; Fu Y; Ma Y
    Eur J Med Res; 2024 Jun; 29(1):326. PubMed ID: 38867322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potential Diagnostic Biomarkers and Biological Pathways in Hypertrophic Cardiomyopathy Based on Bioinformatics Analysis.
    Yu T; Huang Z; Pu Z
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection.
    Yin F; Liu K; Peng W; Jiang D; Zhang H; Guo P; Wu Y; Zhang X; Sun C; Wang Y; Wang H; Han Y
    Oxid Med Cell Longev; 2023; 2023():3918393. PubMed ID: 36819785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis, clustering, and immune cell infiltration analysis of m6A-related genes in patients with acute myocardial infarction-a bioinformatics analysis.
    Liang C; Wang S; Zhang M; Li T
    J Thorac Dis; 2022 May; 14(5):1607-1619. PubMed ID: 35693610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental validation and comprehensive analysis of m6A methylation regulators in intervertebral disc degeneration subpopulation classification.
    Xu X; Shen L; Qu Y; Li D; Zhao X; Wei H; Yue S
    Sci Rep; 2024 Apr; 14(1):8417. PubMed ID: 38600232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and verification of promising diagnostic biomarkers in patients with hypertrophic cardiomyopathy associate with immune cell infiltration characteristics.
    Zheng X; Yang Y; Huang Fu C; Huang R
    Life Sci; 2021 Nov; 285():119956. PubMed ID: 34520765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Verification of Feature Immune-Related Genes in Patients With Hypertrophic Cardiomyopathy Based on Bioinformatics Analyses.
    Zheng X; Liu G; Huang R
    Front Cardiovasc Med; 2021; 8():752559. PubMed ID: 34765659
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis.
    Bai Q; Shi M; Sun X; Lou Q; Peng H; Qu Z; Fan J; Dai L
    Front Endocrinol (Lausanne); 2022; 13():957742. PubMed ID: 36034449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m6A regulator-mediated RNA methylation modification patterns are involved in the regulation of the immune microenvironment in ischaemic cardiomyopathy.
    Zheng PF; Hong XQ; Liu ZY; Zheng ZF; Liu P; Chen LZ
    Sci Rep; 2023 Apr; 13(1):5904. PubMed ID: 37041267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
    Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
    Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial downregulation of nuclear m6A reader YTHDC1 promotes pulmonary vascular remodeling in sugen hypoxia model of pulmonary hypertension.
    Zheng H; Wu D; Chen X; He W; Hua J; Li Q; Ji Y
    Heliyon; 2024 Feb; 10(3):e24963. PubMed ID: 38318069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of diagnostic gene biomarkers for hypertrophic cardiomyopathy by integrated machine learning.
    You H; Dong M
    J Int Med Res; 2023 Nov; 51(11):3000605231213781. PubMed ID: 38006610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning-driven diagnostic signature provides new insights in clinical management of hypertrophic cardiomyopathy.
    Liu S; Yuan P; Zheng Y; Guo C; Ren Y; Weng S; Zhang Y; Liu L; Xing Z; Wang L; Han X
    ESC Heart Fail; 2024 Aug; 11(4):2234-2248. PubMed ID: 38629342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer.
    Ma J; Yang D; Ma XX
    Aging (Albany NY); 2021 Jun; 13(12):16287-16315. PubMed ID: 34230220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the N6-methyladenosine regulatory factor in reducing the risk of cardiovascular disease: subtype diagnosis following aerobic exercise-assisted weight loss.
    Hao X; Li Y; Huang G; Zeng Y
    Am J Transl Res; 2022; 14(8):5363-5378. PubMed ID: 36105062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel insight into m6A regulator-mediated methylation modification patterns and immune characteristics in intracranial aneurysm.
    Li S; Zhang Q; Weng L; Han Y; Li J
    Front Aging Neurosci; 2022; 14():973258. PubMed ID: 36034129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-methyladenosine modulation classes and immune microenvironment regulation in ischemic stroke.
    Tao H; Dong L; Li L
    Front Mol Neurosci; 2022; 15():1013076. PubMed ID: 36762188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.